Clinical trials and meta-analyses have shown that complete-revascularization (CR) during primary PCI decreases the risk of revascularization compared to infarct-related artery-only revascularization (IRA-OR). However, those studies were underpowered to test… Click to show full abstract
Clinical trials and meta-analyses have shown that complete-revascularization (CR) during primary PCI decreases the risk of revascularization compared to infarct-related artery-only revascularization (IRA-OR). However, those studies were underpowered to test hard endpoints such as MI and mortality.
               
Click one of the above tabs to view related content.